These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26333769)

  • 21. Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures.
    Moore YE; Deeb TZ; Chadchankar H; Brandon NJ; Moss SJ
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10166-10171. PubMed ID: 30224498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABA
    Heubl M; Zhang J; Pressey JC; Al Awabdh S; Renner M; Gomez-Castro F; Moutkine I; Eugène E; Russeau M; Kahle KT; Poncer JC; Lévi S
    Nat Commun; 2017 Nov; 8(1):1776. PubMed ID: 29176664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of the neuron-specific K+/Cl- cotransporter expression by transcription factor early growth response 4.
    Uvarov P; Ludwig A; Markkanen M; Rivera C; Airaksinen MS
    J Neurosci; 2006 Dec; 26(52):13463-73. PubMed ID: 17192429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early-onset epileptic encephalopathy with migrating focal seizures associated with a FARS2 homozygous nonsense variant.
    Ville D; Lesca G; Labalme A; Portes VD; Arzimanoglou A; de Bellescize J
    Epileptic Disord; 2020 Jun; 22(3):327-335. PubMed ID: 32597768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cation-chloride cotransporters and GABA-ergic innervation in the human epileptic hippocampus.
    Muñoz A; Méndez P; DeFelipe J; Alvarez-Leefmans FJ
    Epilepsia; 2007 Apr; 48(4):663-73. PubMed ID: 17319917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ionotropic and metabotropic kainate receptor signalling regulates Cl
    Garand D; Mahadevan V; Woodin MA
    J Physiol; 2019 Mar; 597(6):1677-1690. PubMed ID: 30570751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two Japanese cases of epileptic encephalopathy associated with an FGF12 mutation.
    Takeguchi R; Haginoya K; Uchiyama Y; Fujita A; Nagura M; Takeshita E; Inui T; Okubo Y; Sato R; Miyabayashi T; Togashi N; Saito T; Nakagawa E; Sugai K; Nakashima M; Saitsu H; Matsumoto N; Sasaki M
    Brain Dev; 2018 Sep; 40(8):728-732. PubMed ID: 29699863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KCC2 Regulates Neuronal Excitability and Hippocampal Activity via Interaction with Task-3 Channels.
    Goutierre M; Al Awabdh S; Donneger F; François E; Gomez-Dominguez D; Irinopoulou T; Menendez de la Prida L; Poncer JC
    Cell Rep; 2019 Jul; 28(1):91-103.e7. PubMed ID: 31269453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of KCC2 Mutations in Human Epilepsy Suggests Strategies for Therapeutic Transporter Modulation.
    Duy PQ; David WB; Kahle KT
    Front Cell Neurosci; 2019; 13():515. PubMed ID: 31803025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KCC2 activity is critical in limiting the onset and severity of status epilepticus.
    Silayeva L; Deeb TZ; Hines RM; Kelley MR; Munoz MB; Lee HH; Brandon NJ; Dunlop J; Maguire J; Davies PA; Moss SJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3523-8. PubMed ID: 25733865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmentally regulated KCC2 phosphorylation is essential for dynamic GABA-mediated inhibition and survival.
    Watanabe M; Zhang J; Mansuri MS; Duan J; Karimy JK; Delpire E; Alper SL; Lifton RP; Fukuda A; Kahle KT
    Sci Signal; 2019 Oct; 12(603):. PubMed ID: 31615901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered distribution of KCC2 in cortical dysplasia in patients with intractable epilepsy.
    Munakata M; Watanabe M; Otsuki T; Nakama H; Arima K; Itoh M; Nabekura J; Iinuma K; Tsuchiya S
    Epilepsia; 2007 Apr; 48(4):837-44. PubMed ID: 17284302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WNK1/HSN2 mutation in human peripheral neuropathy deregulates KCC2 expression and posterior lateral line development in zebrafish (Danio rerio).
    Bercier V; Brustein E; Liao M; Dion PA; Lafrenière RG; Rouleau GA; Drapeau P
    PLoS Genet; 2013; 9(1):e1003124. PubMed ID: 23300475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KCC2 overexpression prevents the paradoxical seizure-promoting action of somatic inhibition.
    Magloire V; Cornford J; Lieb A; Kullmann DM; Pavlov I
    Nat Commun; 2019 Mar; 10(1):1225. PubMed ID: 30874549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy.
    Kahle KT; Merner ND; Friedel P; Silayeva L; Liang B; Khanna A; Shang Y; Lachance-Touchette P; Bourassa C; Levert A; Dion PA; Walcott B; Spiegelman D; Dionne-Laporte A; Hodgkinson A; Awadalla P; Nikbakht H; Majewski J; Cossette P; Deeb TZ; Moss SJ; Medina I; Rouleau GA
    EMBO Rep; 2014 Jul; 15(7):766-74. PubMed ID: 24928908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study.
    Poisson K; Wong M; Lee C; Cilio MR
    Eur J Paediatr Neurol; 2020 Mar; 25():77-81. PubMed ID: 31926846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical features and gene mutations in epilepsy of infancy with migrating focal seizures].
    Shang KW; Zhang YH; Yang XL; Liu AJ; Yang ZX; Liu XY; Jiang YW; Wu XR
    Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):735-739. PubMed ID: 27784474
    [No Abstract]   [Full Text] [Related]  

  • 38. Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy.
    Pathak HR; Weissinger F; Terunuma M; Carlson GC; Hsu FC; Moss SJ; Coulter DA
    J Neurosci; 2007 Dec; 27(51):14012-22. PubMed ID: 18094240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and molecular characterization of
    McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
    Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early infantile epileptic encephalopathy type 14: three cases of epilepsy in infancy with migrating focal seizures due to KCNT1 mutations].
    Kholin AA; Zavadenko NN; Fedonyuk ID; Antonets AV; Mukhin KY; Malov AG; Vshivkov MI; Anisimov GV; Il'ina ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7. Vyp. 2):74-82. PubMed ID: 31532594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.